Progress in Ebola Virus Vaccine Development

Affiliations

¹ Department of Microbiology and Immunology, Sidney Kimmel Medical College and Jefferson Vaccine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Comment

Matthias J Schnell. J Infect Dis. 2017.

. 2017 Jun 15;215(12):1775-1776.

doi: 10.1093/infdis/jix190.

¹ Department of Microbiology and Immunology, Sidney Kimmel Medical College and Jefferson Vaccine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

No abstract available

Keywords: Ebola vaccine; clinical trail phase III; rhaboviruses; vesicular stomatitis virus.

Comment on

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults.
Halperin SA, Arribas JR, Rupp R, Andrews CP, Chu L, Das R, Simon JK, Onorato MT, Liu K, Martin J, Helmond FA; V920-012 Study Team. Halperin SA, et al. J Infect Dis. 2017 Jun 15;215(12):1789-1798. doi: 10.1093/infdis/jix189. J Infect Dis. 2017. PMID: 28549145 Free PMC article. Clinical Trial.